O
4.73
-0.01 (-0.21%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Oric Pharmaceuticals, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
1.6
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.63 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 9.56% |
| 机构持股比例 | 107.84% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Column Group Llc | 31 Dec 2024 | 3,540,777 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 22.00 (JP Morgan, 365.12%) | 购买 |
| 22.00 (HC Wainwright & Co., 365.12%) | 购买 | |
| 中 | 22.00 (365.12%) | |
| 低 | 12.00 (Oppenheimer, 153.70%) | 购买 |
| 平均值 | 18.67 (294.72%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 6.14 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 09 May 2025 | 22.00 (365.12%) | 购买 | 5.08 |
| 05 May 2025 | 21.00 (343.97%) | 购买 | 5.70 | |
| Oppenheimer | 06 May 2025 | 12.00 (153.70%) | 购买 | 5.04 |
| JP Morgan | 26 Feb 2025 | 22.00 (365.12%) | 购买 | 8.30 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合